Archive for February, 2012
I’m a bit late with this post as February’s PME (Pharmaceutical Market Europe) has been out for a while now. Once again the magazine features the latest print outing for my Digital Intelligence blog.
It asks, after the MHRA approves its first app, whether pharma mobile apps are medical devices. There’s also room for a look at the FDA’s ‘social media’ guidance on off-label information requests, a real-world evidence collaboration between AstraZeneca and IMS Health and much more.
• Read February’s PME in full online
I thought the internet was supposed to kill the newspaper, but the public’s desire for a newspaper service – albeit a digital one – is still going strong, judging by statistics that caught my eye recently.
That’s not, of course, the same as saying things are easy for individual newspapers – if that were the case there would be no need for Newspaper Death Watch – and even some supposedly progressive online-only models are faltering.